NHD Global
Reproductive & Hormone · Source-reviewed dossier
Source-Reviewed Research Dossier
Oxytocin is a short natural peptide with two well-known roles: it causes uterine contractions during labor and milk release during breastfeeding. In the brain, it also acts as a signal, and scientists study possible links to social behavior, stress and maternal care. Those brain-related ideas are still developing; study results depend heavily on the model, how it is given and who is studied. Regulated oxytocin medicines exist, but their approved uses are narrow and tied to specific formulations and routes, such as intravenous or intramuscular obstetric use. A research research material is not that finished medicine. This page separates these categories so readers can see which effects are well established, which remain experimental, and why oxytocin attracts research interest.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A 2024 review summarizes oxytocin synthesis, receptor signaling, pharmacology and clinical research.
A broad review does not validate a specific route or catalog preparation.
Read the primary studyDailyMed lists regulated oxytocin products with defined strengths, routes, warnings and indications.
A regulated label is not evidence that a catalog research material is the same finished drug.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 2 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
A broad review does not validate a specific route or catalog preparation.
View primary recordA regulated label is not evidence that a catalog research material is the same finished drug.
View primary recordThird-party publications selected for direct relevance.
Review. 2024. PMID 38462255.
U.S. National Library of Medicine, DailyMed.
Concise answers for researchers comparing identity, evidence and catalog variants.
The strongest evidence covers reproductive physiology. Oxytocin drives uterine contractions during labor and milk ejection during breastfeeding, and synthetic oxytocin is used in regulated obstetric care to induce or augment labor and to help prevent postpartum hemorrhage after delivery. Brain-related roles in fear, pain, stress and maternal behavior are plausible and actively studied, but the review notes some long-term behavioral and physiological adaptation ideas remain unproven. Those central effects should be treated as a developing research area rather than settled outcomes of any particular preparation.
Endogenous oxytocin physiology, intranasal behavioral experiments, and injectable obstetric medicines represent different evidence categories that should not be pooled. A review article summarizes existing work but does not constitute a new experiment. Regulated labels describe specific finished products, not research catalog material. Catalog identity and lot quality are governed by specifications and lot documents rather than by published clinical studies. Keeping these boundaries clear prevents overreading findings from one route, model or formulation as if they applied to all oxytocin materials.
Physiology and obstetric pharmacology are established, while behavioral effects show major context and study-design dependence.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
Oxytocin is both an endogenous hormone and a regulated prescription drug. Established obstetric uses do not validate every social, mood, bonding or wellness claim…
Updated October 1, 2026
Oxytocin is a cyclic nonapeptide with a Cys1–Cys6 disulfide bridge and a C-terminal amide. Sequence, disulfide state, counterion, aggregation and potency are distinct quality…
Updated October 1, 2026
Read a test-meal result alongside the trial’s main eight-week weight result.
Updated October 11, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: OT2 · 2 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
